21.07

0.84% -0.205

Catalyst Pharmaceuticals Inc (CPRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CPRX Giù? Forum Previsione

Precedente Chiudi:

$21.27

Aprire:

$21.27

Volume 24 ore:

957.47K

Relative Volume:

0.66

Capitalizzazione di mercato:

$2.58B

Reddito:

$460.48M

Utile/perdita netta:

$142.80M

Rapporto P/E:

17.85

EPS:

1.18

Flusso di cassa netto:

$221.79M

1 W Prestazione:

-1.39%

1M Prestazione:

+1.21%

6M Prestazione:

-15.09%

1 anno Prestazione:

-3.65%

Intervallo 1D:

$20.95

$21.74

Intervallo di 1 settimana:

$20.72

$21.74

Portata 52W:

$19.05

$26.58

Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile

Nome

Catalyst Pharmaceuticals Inc

Settore

Healthcare (1139)

Industria

Biotechnology (635)

Telefono

(305) 529-2522

Indirizzo

355 ALHAMBRA CIRCLE, CORAL GABLES

Dipendente

167

Cinguettio

@CatalystForRare

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

CPRX's Discussions on Twitter

Confronta CPRX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CPRX Catalyst Pharmaceuticals Inc	21.06	2.60B	460.48M	142.80M	221.79M	1.18
VRTX Vertex Pharmaceuticals Inc	423.63	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	640.13	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	431.19	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	823.88	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	185.89	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-04	Iniziato	Robert W. Baird	Outperform
2024-11-18	Iniziato	Stephens	Overweight
2024-03-14	Iniziato	Citigroup	Buy
2024-03-07	Iniziato	BofA Securities	Buy
2023-12-21	Iniziato	Oppenheimer	Outperform
2022-08-24	Downgrade	ROTH Capital	Buy → Neutral
2018-09-21	Iniziato	Cantor Fitzgerald	Overweight
2018-09-07	Ripresa	Piper Jaffray	Overweight
2016-10-05	Aggiornamento	Piper Jaffray	Neutral → Overweight
2016-04-26	Downgrade	Piper Jaffray	Overweight → Neutral
2014-09-30	Reiterato	ROTH Capital	Buy
2014-09-16	Reiterato	ROTH Capital	Buy
2014-09-15	Reiterato	H.C. Wainwright	Buy
2013-10-21	Reiterato	Aegis Capital	Buy
2013-09-24	Iniziato	Maxim Group	Buy
2013-09-06	Reiterato	Aegis Capital	Buy
2013-04-18	Iniziato	Aegis Capital	Buy
2012-08-27	Aggiornamento	Rodman & Renshaw	Mkt Perform → Mkt Outperform
2009-10-01	Aggiornamento	Merriman	Sell → Neutral
2009-05-29	Downgrade	Hapoalim	Neutral → Underperform
2009-05-29	Downgrade	Merriman Curhan Ford	Buy → Sell
2008-12-15	Iniziato	Merriman Curhan Ford	Buy
2007-11-28	Iniziato	Rodman & Renshaw	Mkt Outperform
2007-01-31	Iniziato	Stifel Nicolaus	Buy
2007-01-05	Iniziato	First Albany	Buy

Mostra tutto

Catalyst Pharmaceuticals Inc Borsa (CPRX) Ultime notizie

08:21 AM

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference - The Manila Times

08:21 AM

08:03 AM

Catalyst Pharma (Nasdaq: CPRX) at Jefferies Healthcare Conference; webcast 2:00 pm GMT - Stock Titan

08:03 AM

07:30 AM

Momentum divergence signals in Catalyst Pharmaceuticals Inc. chartJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com

07:30 AM

07:25 AM

Is Catalyst Pharmaceuticals Inc. (CN2) stock a buy on weakness2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com

07:25 AM

07:11 AM

Catalyst Pharmaceuticals (CPRX): Exploring Valuation as Shares Remain Steady and Investors Weigh Long-Term Growth - Yahoo Finance

07:11 AM

06:25 AM

Can Catalyst Pharmaceuticals Inc. hit a new high this monthEarnings Overview Report & High Return Stock Watch Alerts - newser.com

06:25 AM

04:50 AM

Will Catalyst Pharmaceuticals Inc. stock split again soon2025 Momentum Check & Daily Stock Momentum Reports - newser.com

04:50 AM

04:45 AM

What analyst consensus says on Catalyst Pharmaceuticals Inc. stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com

04:45 AM

01:01 AM

Will Catalyst Pharmaceuticals Inc. (CN2) stock keep high P E multiplesWeekly Loss Report & Consistent Return Investment Signals - newser.com

01:01 AM

Nov 02, 2025

Is Catalyst Pharmaceuticals Inc. (CN2) stock attractive post correctionPortfolio Growth Summary & Risk Managed Investment Signals - newser.com

Nov 02, 2025

Catalyst Pharmaceuticals Inc. recovery potential after sell offWeekly Trade Report & Entry Point Confirmation Alerts - newser.com

Nov 02, 2025

What risks investors should watch in Catalyst Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com

Nov 02, 2025

Using portfolio simulators with Catalyst Pharmaceuticals Inc. included2025 Key Highlights & High Conviction Investment Ideas - newser.com

Nov 02, 2025

Nov 01, 2025

Applying Elliott Wave Theory to Catalyst Pharmaceuticals Inc.Earnings Growth Report & Real-Time Volume Analysis - newser.com

Nov 01, 2025

Using Bollinger Bands to evaluate Catalyst Pharmaceuticals Inc.Gap Down & Reliable Price Breakout Signals - newser.com

Nov 01, 2025

Price momentum metrics for Catalyst Pharmaceuticals Inc. explainedIndex Update & Technical Pattern Based Buy Signals - newser.com

Nov 01, 2025